Production of microspheres based on hydrophobically associating alginate derivatives by dispersion/gelation in aqueous sodium chloride solutions

Journal of Biomedical Materials Research - Part A

Volumn 68, Issue 2, 2004, Pages 335-342

  Leonard, M ^a   Rastello De Boisseson, M ^a   Hubert, P ^a   Dellacherie, E ^a  

^a LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

Author keywords

Associative alginate; Hydrogels; Microparticles

Indexed keywords

BOND STRENGTH (MATERIALS); CALCIUM COMPOUNDS; CONCENTRATION (PROCESS); HYDROGELS; HYDROPHOBICITY; MICROMETERS; POLYSACCHARIDES; SUSPENSIONS (FLUIDS); WATER;

DODECYL CHAINS; MICROPARTICLES; MICROSPHERES; THIXOTROPIC PROPERTIES;

BIOMEDICAL ENGINEERING;

ALGINIC ACID; CALCIUM CHLORIDE; CALCIUM ION; CATION; MICROSPHERE; POLYSACCHARIDE; SODIUM CHLORIDE; WATER;

AQUEOUS SOLUTION; ARTICLE; CENTRIFUGATION; CONCENTRATION (PARAMETERS); DISPERSION; EXPERIMENT; FREEZE DRYING; GELATION; HYDROGEL; HYDROPHOBICITY; LIQUID; MECHANICAL STRESS; MECHANICS; PARTICLE SIZE; TECHNIQUE; THIXOTROPY;

EID: 1942452912     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20006     Document Type: Article

References (41)

1. Conti B, Giunchedi P, Conte U. Cellulose microparticles in drug delivery. STP Pharm Sci 1997;7:331-342.
2. Mocanu G, Merle L, Carpov A, Muller G. Immobilisation de biomolécules dans des microparticules de carboxyméthylcelluloses "hydrophobiquement modifiées." Eur Polym J 2000;36:2381-2386.
3. Steinitz M, Tamir S. An improved method to create nitrocellulose particles suitables for the immobilization of antigen and antibody. J Immunol Methods 1995;187:171-177.
4. Pereswetoff-Morath L, Edman P. Dextran microspheres as a potential nasal drug delivery system for insulin-in vitro and in vivo properties. Int J Pharm 1995;124:37-44
5. Hennink WE, Franssen O, van Dijk-Wolthuis WNE, Talsma H. Dextran hydrogels for the controlled release of proteins. J Control Rel 1997;48:107-114.
6. Franssen O, Vandernnet L, Roders P, Hennink WE. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J Control Rel 1999;60:211-221.
7. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliver Rev 2001;47:83-97.
8. Uchegbu IF, Schätzlein AG, Tetley L, Gray AI, Sludden J, Siddique S, Mosha E. Polymeric chitosan-based vehicles for drug delivery. J Pharm Pharmacol 1998;50:453-458.
9. Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998;24:979-993.
10. Illum L, Farraj NF, Fischer AN, Gill I, Miglietta M, Benedetti LMN. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. J Control Rel 1994;29:133-141.
11. Benedetti LM, Topp EM, Stella VJ. Microspheres of hyaluronic acid esters. Fabrication methods and in vitro hydrocortisone release. J Control Rel 1990;13:33-41.
12. Heritage PL, Loomes LM, Jianxiong J, Brook MA, Underdown BJ. Novel polymer-grafted starch microparticles for mucosal delivery of vaccines. Immunology 1996;88:162-168.
13. Farraj NF, Johansen BR, Davis SS, Illum L. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J Control Rel 1990;13:253-261.
14. Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliver Rev 1998;31:267-285.
15. Bowersock TL, HogenEsch H, Torregrosa S, Borie D, Wang B, Park H, Park K. Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres. Immunol Lett 1998;60:37-43.
16. Hearn E, Neufeld RJ. Poly(methylene co-guanidine) coated alginate as an encapsulation matrix for urease. Process Biochem 2000;35:1253-1260.
17. Haug A, Larsen B, Smidsrod O. Uronic acid sequence in alginate from different sources. Carbohyd Res 1974;32:217-225.
18. Ertesvag H, Valla S. Biosynthesis and applications of alginates. Polym Degrad Stabil 1998;59:85-91.
19. Takka S, Acartürk F. Calcium alginate microparticles for oral administration. I. effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul 1999;16:275-290.
20. Shapiro L, Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 1997;18:583-590.
21. Eiselt P, Yeh J, Latvala RK, Shea LD, Mooney DJ. Porous carriers for biomedical applications based on alginate hydrogel. Biomaterials 2000;21:1921-1927.
22. Miralles G, Baudoin R, Dumas D, Baptiste D, Hubert P, Stoltz JF, Dellacherie E, Mainard D, Netter P, Payan E. Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res 2001;57:268-278.
23. Bowersock TL, HogenEsch H, Suckow M, Porter RE, Jackson R, Park H, Park K. Oral vaccination with alginate microsphere systems. J Control Rel 1996;39:209-220.
24. Chickering DE, Jacob JS, Desai TA, Harrisson M, Harris WP, Morell CN, Chaturvedi P, Mathiowitz E. Bioadhesive microspheres: an in vivo transit and bioavailability study of drug loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres. J Control Rel 1997;48:35-46.
25. Quong D, Neufeld RJ. Electrophoretic extraction and analysis of DNA from chitosan or polylysine-coated alginate beads. Appl Biochem Biotechnol 1999;81:67-77.
26. Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J Pharm Sci 1993;82:912-917.
27. Ferreiro MG, Tillman LG, Hardee G, Bodmeier R. Alginate/poly-1-lysine microparticles for the intestinal delivery of antisense oligonucleotides. Pharm Res 2002;19:755-764.
28. Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Chitosan-alginate microparticles as protein carrier. Drug Dev Ind Pharm 2001;27:393-401.
29. Shu XZ, Zhu KJ. The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: the preparation method effect. Eur J Pharm Biopharm 2002;53:193-201.
30. Vandenberg GW, Drolet C, Scott SL, de la Noüe J. Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation. J Control Rel 2001;77:297-307.
31. Huguet ML, Neufeld RJ, Dellacherie E. Calcium-alginate beads coated with polycationic polymers: comparison of chitosan and DEAE-dextran. Process Biochem 1996;31:347-353.
32. Chen JP, Chu IM, Shiao MY, Hsu BR, Fu SH. Microencapsulation of islets in PEG-amine modified alginate-poly(lysine)-alginate microcapsules for constructing bioartificial pancreas. J Fermentation Bioeng 1998;86:185-190.
33. Singh ON, Burgee DJ. Characterization of albumin-alginic acid complex coacervation. J Pharm Pharmacol 1989;41:670-673.
34. Lévy MC, Edwards-Lévy F. Coating alginate beads with cross-linked biopolymers: a novel method based on transacylation reaction. J Microencapsul 1996;13:169-183.
35. Pelletier S, Hubert P, Lapicque F, Payan E, Dellacherie E. Amphiphilic derivatives of sodium alginate and hyaluronate: Synthesis and physico-chemical properties of aqueous dilute solutions. Carbohydr Polym 2000;43:343-349.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-255.
37. Sinquin A, Dellacherie E, Hubert P. Amphiphilic derivatives of alginate: evidence for intra- and intermolecular hydrophobic association in aqueous solution. Langmuir 1993;9:3334-3337.
38. Sinquin A, Hubert P, Marchal P, Choplin L, Dellacherie E. Rheological properties of semi-dilute aqueous solutions of hydrophobically-modified propylene glycol alginate derivatives. Colloid Surface A 1996;112:193-200.
39. Fischer A, Houzelle MC, Hubert P, Axelos MAV, Geoffroy-Chapotot C, Carré MC, Viriot ML, Dellacherie E. Detection of intramolecular associations in hydrophobically-modified pectin derivatives using fluorescent probes. Langmuir 1998;14:4482-4488.
40. Pelletier S, Hubert P, Payan E, Choplin L, Marchal P, Dellacherie E. Amphiphilic derivatives of sodium alginate and hyaluronate for cartilage repair: Rheological properties. J Biomed Mater Res 2001;64:102-108.
41. Liu LS, Liu SQ, Ng SY, Froix M, Ohno T, Heller J. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Rel 1997;43:65-74.